PCA - Consumer Peer to Peer Mentoring Program

Palliative Care Australia
As part of its ongoing commitment to provide training and support for consumers, CHF is collaborating with Palliative Care Australia (PCA) to provide ‘Peer to Peer’ mentoring for the members of PCA’s National Register of Palliative Care Consumers and Carers (the National Register).
Deadline: 
2 February 2020

DOH - Medical Research Future Fund (MRFF) Medicinal Cannabis Research Roundtable

Department of Health
The Medical Research Future Fund (MRFF) provides grants of financial assistance to support health and medical research and innovation to improve the health and well-being of Australians. On 6 October 2019, the Minister for Health, the Hon Greg Hunt MP, announced $3 million from the MRFF to examine the benefits of medicinal cannabis for pain, symptom and side effect management for cancer patients. The Department is working to design an open and contestable grant opportunity, which is expected to open in mid-2020. To assist in shaping the overall design of the grant opportunity, the Department will be hosting a stakeholder roundtable on 27 February 2020 in Canberra, ACT.
Deadline: 
2 February 2020

Value in Prescribing Immunoglobulin’s Program Design Forum

NPS MedicineWise
A consortium, led by NPS MedicineWise, aims to develop and deliver educational resources, tools and interventions to support health professionals in optimising the use of precious immunoglobulin products and educate consumers on the role of these products.
Deadline: 
7 February 2020

Medicines Australia Code of Conduct Committee

Medicines Australia
Medicines Australia is the peak industry body representing Australian research-based pharmaceutical companies. The Code of Conduct (the Code) sets out standards of conduct for pharmaceutical companies engaging in the marketing of prescription medicines products. Code provisions include standards for appropriate advertising, the behaviour of medical representatives and relationships with health care professionals. The Code of Conduct Committee considers a range of complaints, and applies penalties and sanctions if the complaint is found to be substantiated.
Deadline: 
14 February 2020

Medicines Australia Code of Conduct Monitoring Committee

Medicines Australia
Medicines Australia is the peak industry body representing Australian research-based pharmaceutical companies. The Code of Conduct (the Code) sets out standards of conduct for pharmaceutical companies engaging in the marketing of prescription medicine products. The Monitoring Committee monitors selected promotional activities of member companies, thereby supporting the quality use of medicines.
Deadline: 
14 February 2020

Australian vaccines study research advisory group

NPS Medicinewise
The Australian Vaccines research project aims to provide evidence on real-world use of the quality use of vaccines, specifically the extent of coverage in Australia for adult and adolescent vaccines recommended in the Australian Immunisation Handbook (both funded and unfunded).
Deadline: 
14 February 2020